Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prognosis of Primary Aldosteronism: A Prospective Cohort Study

NCT07378176 is registered in ClinicalTrials.gov with Xinjiang Medical University as lead sponsor.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07378176 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prognosis of Primary Aldosteronism: A Prospective Cohort Study
Lead sponsor
Xinjiang Medical University
Phase
Observational
Overall status
Recruiting
Start date
January 30, 2026
Completion date
December 31, 2031
Enrollment
5,000 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

primary aldosteronism